COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

about

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

Item

http://www.wikidata.org/entity/Q39320644

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

@en

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

@nl

type

Item

label

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

@en

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

@nl

prefLabel

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

@en

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

@nl

P1476

COX-2 mRNA is increased in oesophageal mucosal cells by a proton pump inhibitor.

@en

P2093

Damian J Hussey

http://www.w3.org/2001/XMLSchema#string

David I Watson

http://www.w3.org/2001/XMLSchema#string

George C Mayne

http://www.w3.org/2001/XMLSchema#string

P2860

Barrett's oesophagus and oesophageal adenocarcinoma: time for a new synthesis

Proton pump inhibitors and gastritis

Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs.

Quantitative, tissue-specific analysis of cyclooxygenase gene expression in the pathogenesis of Barrett's adenocarcinoma.

Prognostic significance of cyclooxygenase-2 (COX-2) expression in patients with surgically resectable adenocarcinoma of the oesophagus

Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus.

Effect of medical and surgical treatment of Barrett's metaplasia

Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.

Targeting of aryl hydrocarbon receptor-mediated activation of cyclooxygenase-2 expression by the indole-3-carbinol metabolite 3,3'-diindolylmethane in breast cancer cells.

Complexity of COX-2 gene regulation.

P304

691-696

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1445-2197.2012.06124.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22758658

http://www.w3.org/2001/XMLSchema#string